Navigate the path from breakthrough science to global oncology execution with Catarina Ribeiro, MD, Alberto Puccini, MD, Martin Forster, MD, Paul Nathan, MBBS, PhD, FRCP and Joao Dias in this webinar hosted by Syneos Health.
Oncology innovation is advancing rapidly, but sponsors must determine which scientific signals are development-ready and scalable across diverse populations, geographies and regulatory environments. The advantage lies in making earlier, evidence-led decisions that connect precision science to operationally viable global programs.
Register for this webinar to learn how to strengthen proof-of-concept decisions, apply predictive intelligence effectively and scale complex oncology programs globally: xtalks.com/webinars/oncology…#SyneosHealth#Oncology#OncologyDrugDevelopment#ClinicalTrials#PrecisionMedicine#Biomarkers#ArtificialIntelligence#ClinicalDevelopment#DrugDevelopment#GlobalClinicalTrials#CancerResearch#Biopharma#LifeSciences
Researchers are investigating VIP signaling as a potential immune checkpoint in cancer. Dr. Ned Waller of Cambium Oncology explains how the pathway may shape an immunosuppressive tumor microenvironment in pancreatic cancer and leukemia, including its effects across T cells, macrophages and cancer cells. Catch insights from the exclusive interview: xtalks.com/targeting-vip-sig…#CancerResearch#Immunotherapy#TumorMicroenvironment#PancreaticCancer#Leukemia
Noninvasive testing, fibrosis assessment and machine learning are changing how researchers think about MASH clinical trials. Dr. Winston Dunn of Summit Clinical Research Solutions and Pinnacle Clinical Research – San Antonio discusses patient screening, risk stratification and the growing need to match treatments to different patient profiles. Read the Xtalks Spotlight interview at xtalks.com/how-noninvasive-t… by @soumya2390.
#CDMO#PharmaceuticalManufacturing#FacilityDesign#SterileManufacturing#Biopharma
Day 2 at the OECT Summit is a done-done!
@kpmorgangroup brought together a strong lineup of speakers tackling some of the biggest conversations shaping clinical trials today, from AI implementation and institutional authorization to patient voice, site engagement, recruitment and the human side of automation.
It has been an exciting two days in Toronto, and we hope the discussions sparked here continue well beyond the summit and lead to even more conversations in the days and weeks ahead.
This has been Xtalks On Location with Insiya, Mohammad and Stephanie.
#OECTSummit#ClinicalTrials#ClinicalResearch#PatientEngagement#Xtalks
Flexible CDMO facilities need to support changing pipelines without adding unnecessary operational complexity. Jason R. Goodwin from @FUJIFILMBiotech discusses equipment selection, automation, vial filling and emerging gloveless technology. Get an exclusive peek from this Xtalks Spotlight interview at buff.ly/fpueQ7b by @soumya2390.
Meet Xtalks Featured Community Member Lorraine Dishman, Clinical Operations & Program Delivery Leader, Behind the Protocol™. Drawing on experience across site, CRO and academic settings, she focuses on turning complex clinical trial strategies into decisions teams can execute while keeping operational realities and patients in view.
Read more: buff.ly/V5NOJ4G#ClinicalOperations#ClinicalResearch#ProgramDelivery#PatientCentricity#XtalksCommunity
Live from the 10th Annual OECT Summit in Toronto today, hosted by @KPMGLOBALS.
The theme — From Prediction to Participation: Transforming Trial Success with AI.
A question: is AI actually moving the needle on feasibility, trial operations and patient recruitment or is there still a gap between promise and practice?
We’re here talking to speakers and listening for the themes that stand out.
#OECkpm#ClinicalResearch#AIinClinicalResearch#LifeSciences#XtalksOnLocation
Xtalks is On Location today at the 10th Annual OECT Summit in Toronto, hosted by @KPMGLOBALS!
Two days, a packed speaker lineup and one question running through much of the agenda: is AI actually delivering in clinical trials, or are we still chasing the hype?
Today’s lineup is digging into where the real progress is, from smarter feasibility and site strategy to patient intelligence and AI-powered clinical operations, and where the gap between promise and practice still shows up.
Proud to be media partners again this year. We’re speaking with clinical research leaders and following the conversations shaping clinical trials today.
#OECkpm#ClinicalResearch#AIinClinicalResearch#ClinicalOperations#LifeSciences#XtalksOnLocation
Overcome cell and gene therapy characterization bottlenecks with Kirsty Maclean and Karthikeyan Devaraju in this webinar hosted by Cerba Research.
As living drugs grow more complex, sponsors need integrated evidence of safety, identity, purity, potency, and sustained therapeutic activity across global programs. Discover how flow cytometry, genomics, and bioanalysis can connect molecular design to cellular function while supporting scalable, standardized development strategies.
Register for this webinar to learn how multi-modality testing can strengthen CGT characterization, reduce translational risk, and support global trial execution: xtalks.com/webinars/bypassin…#CerbaResearch#CellAndGeneTherapy#CGT#CarT#StemCellTherapy#AAV#RNATherapeutics#FlowCytometry#Genomics#Bioanalysis#ClinicalDevelopment#TranslationalScience#Biopharma#ClinicalTrials